RxDoctor Payments Data

Julian Sonnenfeld, MD

Orthopaedic Surgery · Garden City, NYNPI 1700273943

Payments from drug & device makers

What this record shows

This record is dominated by grants: $37,500 of the $59,533 with a category attached, or 63.0%. 14 manufacturers reported payments, led by Arthrex at 36.9% of the total. Reporting peaked in 2020 at $45,472 and has fallen 93.1% since, to $3,149 in 2025.

$59,533in general payments, 2019–2025

Across 57 payments — averaging $1044.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$22K
  • Lima USA, Inc.$18K
  • Smith+Nephew$12K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Peerless Surgical Inc.$2K
  • Zimmer Biomet$1K
  • plus $2K from 8 others

What the payments were for

  • Grants$37,50063%
  • Travel & lodging$2,6784%
  • Food & beverage$2,6975%
  • Education$16,65828%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,533 in reported general payments places this provider in the 85th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$250,088
Medicare patients
315
Services billed
1,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium59$8,142
Naproxen27$176
Ibuprofen13$118
Meloxicam65$107
Methylprednisolone13$66

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Garden City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →